First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients
First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients
Active, not recruiting · NCT06313970 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Phase 2 | 2026-08-26 | NCT06313970 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
| Huadong Hospital | 23 |
| Shanghai Changzheng Hospital | 79 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 128 |
| Huadong Hospital Affiliated to Fudan University | Shanghai | China | 3 |
| The Second Affiliated Hospital of Naval Medical University (Shanghai Changzheng Hospital) | Shanghai | China | 1 |